National Cancer Institute National Cancer Institute
U.S. National Institutes of Health National Cancer Institute
Search
NCI Home Cancer Topics Clinical Trials Cancer Statistics Research & Funding News About NCI
Wilms Tumor and Other Childhood Kidney Tumors Treatment (PDQ®)
Patient VersionHealth Professional VersionEn españolLast Modified: 11/27/2007



General Information






Cellular Classification






Stage Information






Treatment Option Overview






Stage I Wilms Tumor






Stage II Wilms Tumor






Stage III Wilms Tumor






Stage IV Wilms Tumor






Stage V Wilms Tumor






Inoperable Tumors






Clear Cell Sarcoma of the Kidney






Rhabdoid Tumor of the Kidney






Neuroepithelial Tumor of the Kidney






Mesoblastic Nephroma







Renal Cell Carcinoma






Recurrent Wilms Tumor and Other Childhood Kidney Tumors






Get More Information From NCI






Changes to This Summary (11/27/2007)






More Information



Page Options
Print This Page  Print This Page
Print This Document  Print Entire Document
View Entire Document  View Entire Document
E-Mail This Document  E-Mail This Document
Quick Links
Director's Corner

Dictionary of Cancer Terms

NCI Drug Dictionary

Funding Opportunities

NCI Publications

Advisory Boards and Groups

NIH Calendar of Events

Español
NCI Highlights
New Study of Targeted Therapies for Breast Cancer

The Nation's Investment in Cancer Research FY 2009

President's Cancer Panel Annual Report: 2006-2007

Cancer Trends Progress Report: 2007 Update

Past Highlights
HPV Vaccines for Cervical Cancer
Renal Cell Carcinoma

Standard Treatment Options



Standard Treatment Options

The primary treatment for renal cell carcinoma includes total surgical removal of the kidney and associated lymph nodes. There is a report of an initial experience with partial nephrectomy in selected patients to preserve renal function with an outcome comparable to total nephrectomy.[1] There is no evidence that adjuvant therapy is of benefit in children with lymph-node positive, nonmetastatic disease.[2] Treatment of unresectable metastatic disease is presently unsatisfactory but usually includes the use of immune system modulators such as interferon-alpha and interleukin-2.[3] Rare spontaneous regression of pulmonary metastasis may occur with resection of the primary tumor. (Refer to the PDQ summary on adult Renal Cell Cancer Treatment for more information.)

References

  1. Cook A, Lorenzo AJ, Salle JL, et al.: Pediatric renal cell carcinoma: single institution 25-year case series and initial experience with partial nephrectomy. J Urol 175 (4): 1456-60; discussion 1460, 2006.  [PUBMED Abstract]

  2. Geller JI, Dome JS: Local lymph node involvement does not predict poor outcome in pediatric renal cell carcinoma. Cancer 101 (7): 1575-83, 2004.  [PUBMED Abstract]

  3. Fyfe G, Fisher RI, Rosenberg SA, et al.: Results of treatment of 255 patients with metastatic renal cell carcinoma who received high-dose recombinant interleukin-2 therapy. J Clin Oncol 13 (3): 688-96, 1995.  [PUBMED Abstract]

Back to TopBack to Top

< Previous Section  |  Next Section >


A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov